title: Therapeutic potential of intravenously administered human mesenchymal stromal cells.
abstract: Mesenchymal stem cells (MSC) represent a stem and progenitor cell population that has been shown to promote tissue recovery in pre-clinical and clinical studies. The study of MSC migration following systemic infusion of exogenous MSC is difficult. The challenges facing these efforts are due to a number of factors, including defining culture conditions for MSC, the phenotype of cultured MSC, the differences observed between cultured MSC and freshly isolated MSC. However, even if, MSC populations consist of a mixture of stem and more committed multipotent progenitors, it remains probable that these cell populations are still useful in the clinic as discussed in this review.
authors: Institute for Transfusion Medicine and Immune Hematology, Goethe University, Frankfurt, Germany.
authors: K
authors: K
authors: Kollar
authors: E
authors: E
authors: Seifried
authors: R
authors: R
authors: Henschler
mesh_terms: D000818:Animals; D002318:Cardiovascular Diseases / Q000276:immunology* / Q000601:surgery*; D006086:Graft vs Host Disease / Q000276:immunology* / Q000601:surgery*; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D059630:Mesenchymal Stem Cells / Q000276:immunology*